Stay updated on MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial

Sign up to get notified when there's something new on the MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The site revision label was updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-13T12:53:40.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The change appears to be a revision label update from v3.4.0 to v3.4.1; no user-facing content or functionality changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:14:29.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4 instead of Revision: v3.3.3, indicating a minor update with no observable content changes.
    Difference
    0.1%
    Check dated 2026-01-15T04:27:57.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Added a Locations section with Pennsylvania as a listed site. The HHS Vulnerability Disclosure link and the Pennsylvania Locations entry were removed, and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-24T14:52:26.000Z thumbnail image
  6. Check
    91 days ago
    Change Detected
    Summary
    Publications section wording updated to clarify that publications are provided by the person entering information about the study, and the revision number is changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:45:12.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    Notice about government funding and operating status has been removed from the page. All substantive study details (title, eligibility criteria, endpoints, and participation information) remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T07:26:01.000Z thumbnail image

Stay in the know with updates to MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial page.